Goldman double upgrades Croda to ‘buy’, shares spark.
Croda International sparked on Monday after Goldman Sachs double-upgraded the shares to ‘buy’ from ‘sell’ as it said the speciality chemicals firm’s own market-recovery actions have delivered organic sales growth ahead of expectations.
Croda International
23 March 2026 10:54:00
Source: Sharecast
GS noted that Croda has outperformed ingredients peers such as Givaudan, Symrise and DSM-Firmenich.
The bank lifted its FY2026-2027 adjusted EBIT estimates by 13-14%. This reflects "the better 2H25 OSG exit rates, and more optimistic pricing assumptions (in the escalating chemical price environment that is materialising in the context of the Middle East conflict," it said.
Goldman, which has a 3,200p price target on the stock, said adjusted EBIT forecasts for 2026 now sit 6% ahead of expectations.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
